Representations
- During his service on the U.S. Senate Judiciary Committee, Mr. Lazarus participated in hearings on a number of nominations to the Supreme Court and handled numerous legislative matters, including the Federal Rules of Evidence.
- While serving as a White House counsel, he assisted President Ford in his historic testimony before the House Judiciary Committee on the Nixon pardon and also managed the nomination of John Paul Stevens to the Supreme Court.
- He represented an officer of the American Petroleum Institute in federal litigation that resulted in a ruling effectively barring all federal Inspectors General from issuing subpoenas to compel testimony by non-governmental witnesses. See U.S. v. Iannone, 610 F.2d 943 (D.C. Cir. 1979).
- He represented a major participant in the so-called “Iran-Contra Affair” in both Congressional and criminal investigations. See In Re North (Gadd Fee Application), 12 F.3d 252 (D.C.Cir.1994).
- A substantial portion of his practice is devoted to litigation involving the economic interests of physicians. See, e.g., Nilavar v. Mercy Health System, 254 F.Supp.2d 897 (S.D.Ohio 2003) (exclusive dealing antitrust case). He also represents the American Medical Association, the American Osteopathic Association, a number of medical specialty colleges and other physician entities relevant to ongoing efforts to modify the Federal Rules of Civil Procedure and the Federal Rules of Evidence, in accordance with the Rules Enabling Act (28 U.S.C. §§ 2071-77).
- He has represented major corporations incident to trade disputes arising under international treaties and executive agreements and regulatory initiatives conducted by the Geneva-based World Health Organization (WHO).
- Mr. Lazarus, in cooperation with James F. Perna, Esq., also of the D.C. bar, provides legal services incident to the establishment, operation, and defense of off-shore, captive insurance companies for the benefit of U.S. taxpayers. Such companies can provide cost-effective insurance coverage with attendant benefits, including substantial tax savings.
